After completing his BSc (Biology) at Dalhousie University, Ben became involved with projects in the field of medicine at Massachusetts General Hospital. He then went on to complete his medical studies at the First Faculty of Medicine, Charles University, Prague, graduating in 2010.

Rube MA, Immel E, Cox B, Melzer A. Towards Interventional MRI: Semi-Active Device Localization in Phantom Experiments and in a Thiel Embalmed Human Cadaver Model. Oral Presentation, Presented at the 26th International Congress and Exhibition of Computer Assisted Radiology and Surgery, June 2012. Cox BF, Hercogová J, Bürgelová M, Vesely D, Tomí?ková D, Holub M. Gangrenous herpes zoster with multidermatomal involvement in a patient after kidney transplantation. Prague Medical Report. 2011; 112 (1): 44-49 Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D; Fatty Acid Antiarrhythmia Trial Investigators. Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake. Circulation. 2005; 112 (18): 2762-2768 Yong-Fu Xiao, Qingen Ke, Sho-Ya Wang, Yinke Yang, Yu Chen, Ging Kuo Wang, James P. Morgan, Benjamin Cox, Alexander Leaf. Electrophysiologic properties of lidocaine, cocaine and n-3 fatty-acids block of cardiac Na+ channels. European Journal of Pharmacology 2004; 485(1-3): 31-41. Bimalangshu R. Dey, Benjamin Cox, A. Jo Chien, Martin Caron, Steven L. McAfee, Christine Colby, Thomas R. Spitzer. Influence of first-Line regimens on the Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma. Abstract, Presented at the Forty-sixth Annual Meeting of the American Society of Hematology, December, 2004. Thomas R. Spitzer, Benjamin Cox, Paul Sepe, Steven L. McAfee, Bimalangshu R. Dey, Karen Ballan, David Scadden. Dose Adjusted IV Busulfan/Cyclophosphamide (BU/CY) and Autologous (AU) Stem Cell Transplantation (SCT) for Recurrent Lymphoma. Abstract, Presented at the Forty-sixth Annual Meeting of the American Society of Hematology, December, 2004. Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weymouth D, Preffer F, Poliquin C, Foley A, Cox B, Dombkowski D, Andrews D, Sachs DH, Sykes M. The Intentional Induction of Mixed Chimerism and Achievement of Anti-Tumor Responses Following Non-Myeloablative Conditioning Therapy and HLA-Matched and Mismatched Donor Bone Marrow Transplantation for Refractory Hematologic Malignancies. Biology of Blood and Bone Marrow Transplantation 2000; 6: 309-320 Toh HC, McAfee S, Sackstein R, Multani, P, Cox BF, Colby C, Spitzer TR. High Dose (HD) Cyclophosphamide + Carboplatin And Interleukin-2 (IL2) Activated Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) Followed By Subcutaneous (SC) IL2 Therapy In Metastatic Breast Carcinoma (MBC) - A Phase II Study. Bone Marrow Transplant 2000; 25: 19-24 Toh HC, McAfee S, Sackstein R, Cox BF, Colby C, Spitzer TR. Late Onset Veno-Occlusive Disease Following High Dose Chemotherapy and Stem Cell Transplantation. Bone Marrow Transplant 1999; 24: 891-895 Kraus A, Spitzer, TR, McAfee SL, Sackstein R, Toh HC, Multani P, Colby C, Saidman S, Preffer F, Dombkowski D, Weymouth D, Youssef N, Takedatsu H, Cox B, Evans T, Gribben J, Sykes M. Graft-versus-leukema effects, mixed chimerism and early T-cell reconstitution in two patients with advanced stage chronic lymphocytic leukemia after bone marrow transplantation with a novel nonmyeloablative conditioning regimen. Blood 1999;94(suppl 1) 349a. Presented at the Forty-First Annual Meeting of the American Society of Hematology, December, 1999. Kraus A, Spitzer, TR, McAfee SL, Sackstein R, Toh HC, Multani P, Colby C, Saidman S, Preffer F, Dombkowski D, Weymouth D, Cox B, Cosimi AB, Sachs DH, Sykes M. Association of anti-donor reactive cytotoxic T lymphocyte responses with marrow graft rejection following bone marrow transplantation(BMT) with a novel non-myeloablative conditioning regimen: Evidence for split tolerance in a patient with combined kidney and BMT. Blood 1999;94(suppl 1) 349a. Presented at the Forty-first Annual Meeting of the American Society of Hematology, December, 1999. Toh HC, McAfee S, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR. High dose cylophosphamide and carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma: A phase II study. Proc Am Soc Clin Oncol 1999; 16:88a. Oncology, May, 1999 Ana S. Lopes, Richard T. Penson, M.D., Sarah E. Cook, Arlan Fuller, M.D., Annekathryn Goodman, M.D., Ursula Matulonis, M.D., Paul Richardson, M.D., Ross Berkowitz, M.D. Benjamin F. Cox, Steven McAfee, M.D., Dianne Finkelstein, Ph.D., Thomas Spitzer, M.D., Bruce Chabner, M.D., Michael V. Seiden, M.D., Ph.D. Induction Therapy with Immediate Intensification with High Dose Cyclophosphamide, Carboplatin and Continuous Infusion Taxol with Autologous Peripheral Blood Stem Cell Transplantation for the Treatment of Women with Newly Diagnosed and Poor Prognosis Ovarian Carcinoma: A Phase I/II Study. Abstract, New England Cancer Society, November 1998.